Negative Pressure Wound Therapy (NPWT) Market

Negative Pressure Wound Therapy Demand To Boom in Coming Years 


The International Diabetes Federation’s (IDF) Diabetes Atlas Ninth edition 2019 reveals that 374 million individuals are at an increased risk of developing type 2 diabetes and over 1.1 million adolescents and children are living with type 1 diabetes globally. The IDF also forecasts that the number of diabetic patients aged 20–79 years will rise from 463 million in 2019 to 700 million by 2045. These people often suffer from chronic wounds, as diabetes hinders the rapid healing of wounds, thereby leading to the development of diabetic foot ulcers.


Access Report Summary - Negative Pressure Wound Therapy Devices Market Segmentation Analysis Report


Thus, the surging incidence of diabetic foot ulcers will help the negative pressure wound therapy (NPWT) devices market progress at a CAGR of 7.7% during 2020–2030. According to P&S Intelligence, the market revenue will grow from $2,248.1 million in 2020 to $4,698.4 million by 2030. Additionally, the rising cases of burns will also create a huge requirement for NPWT devices in the forthcoming years. As per the World Health Organization (WHO), approximately 180,000 burn-related deaths are recorded every year across the globe. 


At present, conventional NPWT devices are gaining more traction than accessories and single-use NPWT devices, especially in developing countries, such as China and India, which have a vast population. These devices are used to treat chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous ulcers, and acute wounds, such as burns and surgical. In the coming years, these devices will be extensively used for treating chronic wounds among the elderly population, as they are highly prone to chronic venous insufficiency, diabetes mellitus, and peripheral arterial occlusive disease. 


Globally, the North American region led the negative pressure wound therapy devices market in the preceding years due to the surging research and development (R&D) activities and mounting healthcare expenditure in the U.S. and Canada. For example, the Canadian Institute for Health Information (CIHI) states that the healthcare expenditure in Canada increased by 4% per year during 2015–2019. Moreover, the Centers for Medicare and Medicaid Services (CMS) states that $3.8 trillion was spent on healthcare in the U.S. in 2019. 

Thus, the soaring cases of diabetes and burns will facilitate the adoption of NPWT devices in the upcoming years.